Application TACE in primary hepato-cellular carcinoma
Main Article Content
Abstract
SUMMARY
Objectiv and methode: Transcatheter Arterial Chemo- Embolization(TACE) for 23 patients suffered from HCC (Hepato-
Cellular Carcinoma) with 34 times of embolization.
Results: The tumoral diameter is decreased after 1, 3 months
but no statically significant. The intra-tumoral hypervascularity is changing corresponding to the AFP level and the Lipiodol deposition. Some serum biochemical index such as GOT, GPT and Bilirubin are decresed but not statistically significant. Postembolization syndrome appeared in short time. Mean survival
time is 15,25 ± 9,04 months. Life standard quality is improved.
Conclusion: TACE is a palliativ treatment method however it can offer good result such as prolonging survival time and improving life standard quality.
Article Details
References
1. Nguyễn Khánh Trạch, Phạm Thị Thu Hồ (1997) Ung thư gan nguyên phát. Bài giảng Bệnh học Nội khoa tập II, tr167-174.
2. Trịnh Văn Quang (2002). Những khối u gan. Bách khoa thư ung thư học. NXB Y học, tr166-183.
3. Lê Anh Tuấn (2003). Đánh giá kết quả điều trị ung thư biểu mô tế bào gan bằng nút hóa chất động mạch gan. Luận văn tốt nghiệp bác sĩ nội trú.
4. Phạm Hoàng Anh, Trần Hồng Trường, Nguyễn Hoài Nga (1995). Ung thư ở người Hà Nội. Tạp chí Y học thực hành số 11, tr 96-98.
5. Matsuo N, Uchida H, Sakaguchi H, Nishimine K, Nishimura Y, Hirohashi S, Ohishi H (1997). Optimal Lipiodol volume in transcatheter arterial chemoembotherapy for Hepatocellular Carcinoma: Study based on Lipiodol accumulation patterns and
histopathologic findings.
6. Group d’ etude et traitement du carcinome hepatocellulaire (1995). A comparision of Lipiodol chemoembolization and conservative treatment for
unresectable Hepatocellular Carcinoma. New England Journal Medicine May 11, 322(19): 1256-61.